Characterization of unique DNA-binding and transcriptional-activation functions in the carboxyl-terminal extension of the zinc finger region in the human vitamin D receptor
Jc. Hsieh et al., Characterization of unique DNA-binding and transcriptional-activation functions in the carboxyl-terminal extension of the zinc finger region in the human vitamin D receptor, BIOCHEM, 38(49), 1999, pp. 16347-16358
The vitamin D receptor (VDR) binds 1,25-dihydroxyvitamin D-3 and mediates i
ts actions on gene transcription by heterodimerizing with retinoid X recept
ors (RXRs) on direct repeat (DR+3) vitamin D responsive elements (VDREs) lo
cated in target genes. The VDRE binding function of VDR has been primarily
ascribed to the zinc finger region (residues 24-87). To define the minimal
VDRE binding domain for human VDR (hVDR), a series of C-terminally truncate
d hVDR mutants (Delta 134, Delta 113, Delta 102, Delta 90, Delta 84, Delta
80, and Delta 60) was generated and expressed in bacteria. Only the Delta 1
34 and Delta 113 mutants bound the VDRE (predominantly as monomers), sugges
ting that, in addition to the conserved zinc finger region of hVDR as many
as 25 amino acids in a C-terminal extension (CTE) participate in DNA bindin
g. Site-directed mutagenesis of conserved charged residues in full-length h
VDR was then performed to dissect the functional significance of the CTE (r
esidues 88-112) in the context of the complete hVDR-RXR-VDRE interaction. F
unctional assays revealed that E98K/E99K, R102A/K103A/R104A, and K109A/ R11
0A/K111A mutant hVDRs possessed dramatically reduced DNA binding and transc
riptional activities, whereas distinct point mutants, such as K103A, bound
to DNA normally but lacked transcriptional activity. Therefore, the boundar
y for the minimal DNA-binding domain in hVDR extends C-terminal of the zinc
fingers to Lys-111, with clusters of highly conserved charged amino acids
playing a crucial role in binding to the DR+3 element. Further, individual
residues in this region (e.g., Lys-103) may lie on the opposing face of a D
NA-binding or-helix, where they could contact transcriptional coactivators
or basal transcription factors.